Brought to you by 
Merlin, other VCs invest $5.5mm in Amedis Pharmaceuticals
13 Jul 2001
Executive Summary
Amedis Pharmaceuticals (computational chemistry, bioinformatics) received $5.5mm (UK4mm) from a private financing round led by Merlin Biosciences (which invested UK2.5mm).
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- ADMET
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com